Hypothesis

3 Matching Annotations

Last 7 days
www.sciencedirect.com www.sciencedirect.com

Biomarker study of pembrolizumab in patients with advanced rare cancers

1
1. scibot 17 Jun 2026
  
  in Public
  
  RRID:AB_61027
  
  DOI: 10.1016/j.xcrm.2026.102827
  
  Resource: (Lab Vision Cat# MS-457-S, RRID:AB_61027)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_61027
  
  What is this?
  
  RRID:AB_61027
Visit annotations in context

Tags

RRID:AB_61027

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379126002442
Aug 2024
www.sciencedirect.com www.sciencedirect.com

Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial

1
1. scibot 22 Aug 2024
  
  in Public
  
  RRID:AB_61027
  
  DOI: 10.1016/j.medj.2024.07.022
  
  Resource: (Lab Vision Cat# MS-457-S, RRID:AB_61027)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_61027
  
  What is this?
  
  RRID:AB_61027
Visit annotations in context

Tags

RRID:AB_61027

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666634024003039
Sep 2020
www.sciencedirect.com www.sciencedirect.com

Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma

1
1. scibot 16 Sep 2020
  
  in Public
  
  RRID:AB_61027
  
  DOI: 10.1016/j.ccell.2020.04.002
  
  Resource: (Lab Vision Cat# MS-457-S, RRID:AB_61027)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:AB_61027
  
  What is this?
  
  RRID:AB_61027 RRIDCUR:Validated
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:AB_61027

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610820301641